TIANYUAN HEALTH (00557) released its interim results, with the profit attributable to shareholders reaching HKD 4.2 million, marking a year-on-year turnaround to profitability.
Tian Yuan Medical (00557) announced its interim results for the six months ending June 30, 2026. The group achieved a revenue of HKD 20.047 million, representing a year-on-year increase of 137.64%; the profit attributable to equity holders of the company was HKD 4.2 million, turning a loss into a profit year-on-year; earnings per share were HKD 1.05.
TIANYUAN HEALTH (00557) announced its interim results for the six months ending June 30, 2026, reporting a turnover of HKD 20.047 million, a year-on-year increase of 137.64%. The profit attributable to equity holders of the company was HKD 4.2 million, reversing the previous year's loss, with earnings per share of HKD 1.05 cents.
The announcement stated that the reduction in losses was primarily due to an increase in total revenues of approximately HKD 11.6 million during the period, and a change in the expected credit loss from a reversal of about HKD 2.5 million in the same period last year to a recognized expected credit loss of about HKD 1 million.
Related Articles

BOAN BIOTECH (06955) spent HKD 7.471 million on August 28 to repurchase 2 million shares.

BJ DIGITAL (06188) announced its interim results, reporting a net loss attributable to shareholders of 108 million yuan, an increase of 41.4% year-on-year.

CHONGQING M&E (02722): Empowerment Center Submits Bankruptcy Liquidation Application
BOAN BIOTECH (06955) spent HKD 7.471 million on August 28 to repurchase 2 million shares.

BJ DIGITAL (06188) announced its interim results, reporting a net loss attributable to shareholders of 108 million yuan, an increase of 41.4% year-on-year.

CHONGQING M&E (02722): Empowerment Center Submits Bankruptcy Liquidation Application

RECOMMEND





